ITCI
Intra-Cellular Therapies Inc.
62.82
USD
This page is just a preview of the data found in TrendSpider’s full version
Intra-Cellular Therapies Inc. stock is up 14.24% since 30 days ago. The next earnings date is Feb 28, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 70% of the previous 10 December’s closed higher than November. In the last 10 Unusual Options Trades, there were 1 PUT, 9 CALLs.
| Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
|---|---|---|---|---|---|
| 14 Nov 18:31 | 20 Dec, 2024 | 55.00 | 427 | ||
| 14 Nov 20:37 | 17 Nov, 2023 | 50.00 | 368 | ||
| 16 Nov 15:23 | 15 Dec, 2023 | 50.00 | 66 | ||
| 22 Nov 17:35 | 19 Jan, 2024 | 60.00 | 768 | ||
| 28 Nov 15:21 | 19 Jan, 2024 | 60.00 | 880 | ||
| 28 Nov 15:36 | 16 Feb, 2024 | 60.00 | 307 | ||
| 28 Nov 16:14 | 19 Jan, 2024 | 60.00 | 880 | ||
| 28 Nov 19:05 | 19 Jan, 2024 | 60.00 | 880 | ||
| 28 Nov 19:12 | 16 Feb, 2024 | 60.00 | 307 | ||
| 28 Nov 19:15 | 17 May, 2024 | 65.00 | 113 |
Intra-Cellular Therapies, Inc. develops novel drugs for the treatment of neuropsychiatric and neurologic diseases. The company offers CAPLYTA for schizophrenia in adults. It is also involved in developing lumateperone, which is in Phase III clinical trial for bipolar depression, as well as to treat autism spectrum disorder.
